Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report report published on Tuesday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Tuesday. The company has a market capitalization of $681.00, a P/E ratio of 0.00 and a beta of 3.77. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.05.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.